<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30446972</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1880-4233</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                        <Day>16</Day>                    </PubDate>                </JournalIssue>                <Title>Breast cancer (Tokyo, Japan)</Title>                <ISOAbbreviation>Breast Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Clinicopathological features of breast cancer in Japanese female patients with Lynch syndrome.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12282-018-0931-z</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lynch syndrome (LS) is a predominantly inherited syndrome caused by a pathological germline mutation in one of the mismatch repair (MMR) genes. Whether breast cancer (BC) is one of the LS-associated tumors is controversial. The aim of this retrospective cohort study was to evaluate the clinical features of BC in Japanese patients with LS.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Of 38 mutation carriers, 4 females with BC were examined in this study.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Two of the four patients had multiple BC. Their median age at the diagnosis of BC was 63 (range, 47-84) years. The TNM (6th revision) stages of the six BCs were as follows: stage I, 33% (2/6); stage IIA, 50% (3/6); and stage IIB, 17% (1/6). Histological examination revealed four scirrhous, one papillotubular, and one medullary carcinoma. The positive ratios for estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth receptor 2 (HER2) were 83.3% (5/6), 83.3% (5/6), and 16.7% (1/6), respectively. Two of the three specimens showed MSI-H and one showed MSS. These MSI-H BCs had tumor-infiltrating lymphocytes. Two of the three specimens showed an absence of MLH1 and PMS2 proteins on immunohistochemistry. The cumulative risks for a person with LS to develop BC were 4.35% at the age of 50 years, 8.70% at 60 years, and 21.5% at 70 years.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study results showed BC in Japanese females with LS to be an MSI-H tumor, which was ER and PgR positive and HER2 negative.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kanaya</LastName>                    <ForeName>Nobuhiko</ForeName>                    <Initials>N</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0427-4426</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Iwakuni Clinical Center, Yamaguchi, Japan. nov19841026@okayama-u.ac.jp.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, 700-8558, Okayama, Japan. nov19841026@okayama-u.ac.jp.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tanakaya</LastName>                    <ForeName>Kohji</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Iwakuni Clinical Center, Yamaguchi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Yamasaki</LastName>                    <ForeName>Rie</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Iwakuni Clinical Center, Yamaguchi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Arata</LastName>                    <ForeName>Takashi</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Iwakuni Clinical Center, Yamaguchi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shigeyasu</LastName>                    <ForeName>Kunitoshi</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, 700-8558, Okayama, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Aoki</LastName>                    <ForeName>Hideki</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Iwakuni Clinical Center, Yamaguchi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Morito</LastName>                    <ForeName>Toshiaki</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Pathology, Iwakuni Clinical Center, Yamaguchi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Sanaii</LastName>                    <ForeName>Hiromi</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gynecology, Yamaguchi Prefectural Grand Center, Yamaguchi, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Akagi</LastName>                    <ForeName>Kiwamu</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Saitama, Japan.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fujiwara</LastName>                    <ForeName>Toshiyoshi</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, 700-8558, Okayama, Japan.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>11</Month>                <Day>16</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Japan</Country>            <MedlineTA>Breast Cancer</MedlineTA>            <NlmUniqueID>100888201</NlmUniqueID>            <ISSNLinking>1340-6868</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast cancer</Keyword>            <Keyword MajorTopicYN="N">Lynch syndrome</Keyword>            <Keyword MajorTopicYN="N">Mismatch repair gene</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>23</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30446972</ArticleId>            <ArticleId IdType="doi">10.1007/s12282-018-0931-z</ArticleId>            <ArticleId IdType="pii">10.1007/s12282-018-0931-z</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>